Ningbo No.2 Hospital
Clinical trials sponsored by Ningbo No.2 Hospital, explained in plain language.
-
Can an immune booster keep liver cancer away after surgery?
Disease control Not yet recruitingThis early-phase study will test whether adding peginterferon alfa-2b to standard antiviral drugs can help prevent hepatitis B-related liver cancer from coming back after surgery. About 156 adults aged 18 to 65 will receive either the combination or antivirals alone. Researchers …
Phase: EARLY_PHASE1 • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to perfect heart pacing lead placement
Disease control Not yet recruitingThis trial tests two different heart pacing leads—one without a hollow core (lumenless) and one with a stylet—to see which works better for left bundle branch pacing. About 288 people with slow heart rhythms will take part. Doctors will use continuous monitoring to guide the lead…
Phase: NA • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
500 patients to help unlock secrets of knee recovery
Knowledge-focused Not yet recruitingThis study will follow 500 people with knee injuries or knee osteoarthritis who receive standard care at a hospital in China. Researchers will collect medical history, imaging, and function tests at the start and then again at 6, 12, and 24 months. The goal is to better understan…
Sponsor: Ningbo No.2 Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC